1. Toblli JE, Ferder L, Stella I, et al. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol. Jul; 2001; 166: 275-80.
2. Okada H, Strutz F, Danoff TM. Possible pathogenesis of renal fibrosis. Kidney Int, suppl, 1996; 54: S37.
3. Scheid C, Koul H, Hill WA. Oxalate toxicity in LLC-PK1 cells: Role of free radicals. Kidney Int, 1996; 49: 413.
4. Toblli JE, Ferder L, Stella I, et al. Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol. Oct. 2002; 168: 1550-5.
5. Ichikawa I, Harris RC. Angiotensin actions in kidney: Renewed insight into old hormone. Kidney Int., 1991; 40: 583.
6. De Cavanaugh EM, Fraga CG, Ferder L. Enapril and captopril enhance antioxidant defences in mouse tissue. Am Physiol, 1997; 272: R514.
7. Eliahou H, Avinoach I, Shahmurov M. Renoprotective effect of angiotensin II receptor antagonists in experimental chronic renal failure. Am J Nephrol. Jan-Feb. 2001; 21: 78-83.
8. Toblli JE, Ferder L, Stella I, et al. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol. Jul; 166(1): 275-80, 2001.
9. Huang HS, Ma MC, Chen J, Chen CF. Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol. Jun. 2002; 167: 2584-93.
10. Eddy AA. Expression of the genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int, suppl., 1996; 54: S49.
11. Remuzzi G, Ruggenenti P, Benigni A. Understanding the nature of renal disease progression. Kidney Int, 1997; 51: 2.
12. Eddy AA. Molecular insight into renal interstitial fibrosis. J Am Soc Nephrol, 1996; 7: 2495.
13. Poli G, Parola M. Oksidative stress and fibrogenesis. Fr. Radic Biol Med, 1997; 22: 287.
14. Goncalves AR, Fujihara CK, Mattar AL, et al. Expression of cox-2, angiotensin II and the AT1 receptor in remnant kidneys. Strong renoprotection by therapy with losartan and a nonsteroidal antiinflammatory. Am J Physiol Renal Physiol. Dec 2003; 16.
15. Eliahou H, Avinoach I, Shahmurov M, et al. Renoprotective effect of angiotensin II receptor antagonists in experimental chronic renal failure. Am J Nephrol. Jan-Feb. 2001; 21: 78-83.